Percy H. Carter - Jun 1, 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Chief Scientific Officer
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 04:18 PM
Previous filing
May 21, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Award $0 +21.8K $0.00 21.8K Jun 1, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Award $0 +39.2K $0.00 39.2K Jun 1, 2021 Common Stock 39.2K $89.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the Reporting Person's receipt of a grant of 21,843 restricted stock units under the Issuer's 2020 Inducement Plan.
F2 This option vests with respect to 25% of the shares underlying the option on June 1, 2022 and as to an additional 1/48th of the shares underlying the option each month thereafter.